Concourse Financial Group Securities, Inc. Senti Biosciences, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share
Q2 2024 Jul 23, 2024	BUY	$0.24 - $0.4 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$0.36 - $0.66 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.28 - $0.68 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.41 - $0.99 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.41 - $0.99 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$0.6 - $1.14 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.15 - $2.06 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.25 - $65.2 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.33 - $21.7 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.97 - $10.0 $0 - $0

Others Institutions Holding SNTI

# of Institutions

Shares Held

8.79M

Call Options Held

Put Options Held

View Full List

About Senti Biosciences, Inc.

Ticker SNTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,757,100
Market Cap $95.8M
Description
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...

More about SNTI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account